1. Academic Validation
  2. In vitro and in vivo studies of the metabolic activation of 8-epidiosbulbin E acetate

In vitro and in vivo studies of the metabolic activation of 8-epidiosbulbin E acetate

  • Chem Res Toxicol. 2015 Sep 21;28(9):1737-46. doi: 10.1021/acs.chemrestox.5b00174.
Dongju Lin Xiucai Guo Huiyuan Gao Li Cheng Maosheng Cheng Shaojiang Song Ying Peng Jiang Zheng 1
Affiliations

Affiliation

  • 1 Center for Developmental Therapeutics, Seattle Children's Research Institute, Division of Gastroenterology and Hepatology, Department of Pediatrics, University of Washington School of Medicine , Seattle, Washington 98101, United States.
Abstract

Furanoid 8-epidiosbulbin E acetate (EEA) is a major constituent of herbal medicine Dioscorea bulbifera L. (DB), a traditional Chinese medicine herb. Our preliminary studies demonstrated that administration of EEA caused acute hepatotoxicity in mice, and the observed toxicity required cytochromes P450-mediated metabolism. Metabolic activation studies of EEA were performed in vitro and in vivo. Microsomal incubations of EEA supplemented with N-acetyl lysine (NAL) and glutathione (GSH) generated six metabolites (M1-M6). M1-M4 were characterized as pyrrole derivatives, and M5 and M6 were pyrrolinones. M2-M6 were detected in bile and/or urine of rats given EEA. Dimethyldioxirane-mediated oxidation of EEA in the presence of NAL and GSH produced M1-M6, all of which were generated in microsomal incubations. The structures of M3 and M6 were confirmed by (1)H and (13)C NMR. These findings provide evidence for the metabolic activation of EEA to the corresponding cis-enedial intermediate both in vitro and in vivo. Ketoconazole inhibited the microsomal production of the cis-enedial, and P450 3A4 was found to be the primary Enzyme involved in the bioactivation of EEA.

Figures
Products